FDA Approved: SODIUM NITROPRUSSIDE — Supplemental Application (Mylan Institutional LLC)

View source ↗

Summary

FDA approved a supplemental application for a generic sodium nitroprusside product manufactured by Mylan Institutional LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Hypertensive Emergency

Drugs mentioned

• Sodium nitroprusside (sodium nitroprusside)

Snippet

SUPPL AP for SODIUM NITROPRUSSIDE (SODIUM NITROPRUSSIDE)